Product Information

FAMOTIDINE 40 MG/5 ML SUSP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.2803 per ML under NDC 00832604515. Its NADAC has been published 78 times since Sep 18, 2024.

FDA first approved this application on Jun 16, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Famotidine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FAMOTIDINE 40 MG/5 ML SUSP

Famotidine
$0.2803per ML
High Outlier

Strength

40 mg/5mL

NDC

00832604515

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

3/19/2025

Active Ingredients

FAMOTIDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA217655

FDA Approved

6/16/2023

TE Code

AB

On Market Since

6/16/2023

Pharmacological Classes

Histamine H2 Receptor Antagonists
Histamine-2 Receptor Antagonist

Price Statistics

The NADAC for FAMOTIDINE 40 MG/5 ML SUSP has been published 78 times since Sep 18, 2024, and over the history we have for it it has risen 3.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2803 per ML
All-time high$0.2803 (Mar 11, 2026)
All-time low$0.2709 (Sep 18, 2024)
52-week high$0.2803
52-week low$0.2803
Median price$0.2803
Average price$0.2797
Largest weekly change+3.5% (Oct 23, 2024)
Weeks tracked78
Tracking sinceSep 18, 2024

Price History

1W

N/A

1M

N/A

3M

N/A

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+3.5%

Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FAMOTIDINE 40 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for FAMOTIDINE 40 MG/5 ML SUSP, manufactured by Upsher-Smith Laboratories LLC, is $0.2803 per ML (NDC 00832604515), effective Mar 11, 2026.

How has the price of FAMOTIDINE 40 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for FAMOTIDINE 40 MG/5 ML SUSP has risen 3.5%. It has been tracked across 78 weekly CMS publications since Sep 18, 2024.

What are the highest and lowest recorded NADAC prices for FAMOTIDINE 40 MG/5 ML SUSP?

Since Sep 18, 2024, the NADAC for FAMOTIDINE 40 MG/5 ML SUSP has ranged from a low of $0.2709 (Sep 18, 2024) to a high of $0.2803 (Mar 11, 2026), with a median of $0.2803 per ML.

Are there cheaper alternatives to FAMOTIDINE 40 MG/5 ML SUSP?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FAMOTIDINE 40 MG/5 ML SUSP, is $0.1311 per ML — about 53% below FAMOTIDINE 40 MG/5 ML SUSP.

Who manufactures FAMOTIDINE 40 MG/5 ML SUSP?

FAMOTIDINE 40 MG/5 ML SUSP (NDC 00832604515) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.